Quentin Lecocq
7PUBLICATIONS
27CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (7)
Sort by Publication Date:
|May 02, 2022
Targeted Radionuclide Therapy with Low and High-Dose Lutetium-177-Labeled Single Domain Antibodies Induces Distinct Immune Signatures in a Mouse Melanoma Model.Thomas Ertveldt, Lien De Beck, Kirsten De Ridder
|Nov 02, 2021
Evaluation of single domain antibodies as nuclear tracers for imaging of the immune checkpoint receptor human lymphocyte activation gene-3 in cancer.Q Lecocq, P Debie, J Puttemans
|Jul 02, 2021
Site-Specific Radiolabeling of a Human PD-L1 Nanobody via Maleimide-Cysteine Chemistry.Dora Mugoli Chigoho, Quentin Lecocq, Robin Maximilian Awad
|Dec 30, 2020
The Next-Generation Immune Checkpoint LAG-3 and Its Therapeutic Potential in Oncology: Third Time's a Charm.Quentin Lecocq, Marleen Keyaerts, Nick Devoogdt
|Dec 03, 2020
Targeting Neuropilin-1 with Nanobodies Reduces Colorectal Carcinoma Development.Yannick De De Vlaeminck, Stefano Bonelli, Robin Maximilian Awad
|Oct 02, 2020
Anti-human PD-L1 Nanobody for Immuno-PET Imaging: Validation of a Conjugation Strategy for Clinical Translation.Jessica Bridoux, Katrijn Broos, Quentin Lecocq
Pageof 2
Frequent Collaborators
7 joint publications
Karine Breckpot
5 joint publications
Marleen Keyaerts
5 joint publications
Nick Devoogdt
3 joint publications
Pieterjan Debie
3 joint publications
Yannick De Vlaeminck
2 joint publications
Janik Puttemans
2 joint publications
Robin Maximilian Awad
2 joint publications
Lien De Beck
2 joint publications
Thomas Ertveldt
2 joint publications
Cleo Goyvaerts
